Brief: Hyundai IBT signs contract worth 11.82 bln won

Hyundai Bioscience Co

27/07/2017 04:09

July 27 (Reuters) - Hyundai IBT Co Ltd  048410.KQ  : 
     
    * Says it signed a 11.82 billion won contract with Chong Kun 
Dang Pharmaceutical Corp to provide C12  
 
     
    Source text in Korean: https://goo.gl/tBfBt8 
    Further company coverage:  048410.KQ  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: hedy.cui.reuters.com@reuters.net))